$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"

특허 상세정보

Methods of treating metastatic colorectal cancer with ST receptor binding compounds

국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판) A61K-051/00    A61K-039/395    A61K-034/40    A61M-036/14   
미국특허분류(USC) 424/149 ; 424/016.9 ; 424/183.1 ; 435/072.1 ; 435/072.3 ; 435/071 ; 514/02 ; 514/012 ; 514/013 ; 514/014 ; 514/773 ; 530/388.2 ; 530/388.8 ; 530/388.85 ; 530/389.7 ; 530/324 ; 530/325 ; 530/326 ; 530
출원번호 US-0583447 (1996-01-05)
발명자 / 주소
출원인 / 주소
대리인 / 주소
    Woodcock Washburn Kurtz Mackiewicz & Norris, LLP
인용정보 피인용 횟수 : 64  인용 특허 : 27
초록

Conjugated compounds which comprises an ST receptor binding moiety and a radiostable active moiety are disclosed. Pharmaceutical compositions comprising a pharmaceutically acceptable carrier or diluent, and a conjugated compound which comprises an ST receptor binding moiety and a radiostable active moiety or an ST receptor binding moiety and a radioactive active moiety are disclosed. Methods of treating an individual suspected of suffering from metastasized colorectal cancer comprising the steps of administering to said individual a pharmaceutical compos...

대표
청구항

[ I claim:] [1.] A method of treating an individual suspected of suffering from metastasized colorectal cancer comprising the step of administering parenterally to said individual a pharmaceutical composition comprising a therapeutically effective amount of a conjugated compound comprising:a) a ST receptor binding moiety; and,b) an active moiety; rein said active moiety is a radiostable active agent that is a radiostable therapeutic agent.

이 특허에 인용된 특허 (27)

  1. Hata Hitoshi (Ichihara JPX). Additive for lubricating oil and lubricating oil composition containing said additive. USP1992075133886.
  2. Goers John W. F. (Atascadero CA) King Hurley D. (Yardley PA) Lee Chyi (New Brunswick NJ) Coughlin Daniel J. (Plainsboro NJ) Alvarez Vernon L. (Morrisville PA) Rodwell John D. (Yardley PA) McKearn Tho. Antibody-therapeutic agent conjugates. USP1989094867973.
  3. Cody Donna R. (Saline MI) DeWitt Sheila H. H. (Dexter MI) Hodges John C. (Ann Arbor MI) Kiely John S. (Ann Arbor MI) Moos Walter H. (Oakland CA) Pavia Michael R. (Newton MA) Roth Bruce D. (Ann Arbor . Apparatus for multiple simultaneous synthesis. USP1994065324483.
  4. Myers Andre E. (Genevea CHX) Bichon Daniel (Thorens-Glieres FRX). Cytotoxic drug conjugates and their delivery to tumor cells. USP1992025087616.
  5. Ladner Robert C. (Ijamsville MD) Guterman Sonia K. (Belmont MA) Roberts Bruce L. (Milford MA) Markland William (Milford MA) Ley Arthur C. (Newton MA) Kent Rachel B. (Boxborough MA). Directed evolution of novel binding proteins. USP1993065223409.
  6. Thumma Mark R. (Oberlin PA). Electrical connector with shorting contacts. USP1994115366382.
  7. Pirrung Michael C. (Durham NC) Read J. Leighton (Palo Alto CA) Fodor Stephen P. A. (Palo Alto CA) Stryer Lubert (Stanford CA). Large scale photolithographic solid phase synthesis of an array of polymers. USP1995045405783.
  8. Pirrung Michael C. (Durham NC) Read J. Leighton (Palo Alto CA) Fodor Stephen P. A. (Palo Alto CA) Stryer Lubert (Stanford CA). Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof. USP1992095143854.
  9. Ceriani Roberto L. (1089 Via Roble Lafayette CA 94549) Peterson Jerry A. (5916 Chabot Rd. Oakland CA 94618). Method and compositions for carcinoma diagnosis. USP1986044584268.
  10. Kauvar Lawrence M. (San Francisco CA). Method of identity analyte-binding peptides. USP1990104963263.
  11. Welt Sydney (New York NY) Divgi Chaitanya R. (New York NY) Yeh Samual (New York NY) Old Lloyd J. (New York NY) Oettgen Herbert F. (New Canaan CT) Real Francisco X. (Barcelona ESX) Sakamoto Junichi (C. Method of imaging colorectal carcinoma lesion and composition for use therein. USP1992115160723.
  12. Kauvar Lawrence M. (San Francisco CA). Method to produce immunodiagnostic reagents. USP1993065217869.
  13. Dillon Patrick J. (Bloomfield NJ) Rosen Craig A. (Glen Ridge NJ). Methods for producing proteins which bind to predetermined antigens. USP1995035395750.
  14. Campbell David A. (Redwood Shores CA). Methods for the synthesis of phosphonate esters. USP1995055420328.
  15. Waldman Scott A. (Ardmore PA). Methods of diagnosing colorectal tumors and metastasis thereof. USP1997025601990.
  16. Kauvar Lawrence M. (San Francisco CA). Panels of analyte-binding ligands. USP1994085340474.
  17. Schatz Peter J. (Los Altos CA) Cull Millard G. (Oakland CA) Miller Jeff F. (Los Angeles CA). Peptide library and screening method. USP1993125270170.
  18. Schatz Peter J. (Mountain View CA) Stemmer Willem P. C. (Menlo Park CA). Peptide library and screening method. USP1994085338665.
  19. Garbers David L. (Dallas TX) Schulz Stephanie (Dallas TX). Purified enterotoxin receptor protein. USP1993085237051.
  20. Waldman Scott A. (Ardmore PA). ST receptor binding compounds and methods of using the same. USP1996055518888.
  21. Coolidge Thomas R. (Falls Village CT) Lewis William (Lincoln NE) Schuster Sheldon M. (Gainesville FL) Wylie Dwane (Lincoln NE) Wagner Fred W. (Walton NE) Stout Jay (Lincoln NE) van Heeke Gino (Gaines. Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques. USP1993065221736.
  22. Ellman Jonathan A. (Berkeley CA). Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support. USP1994025288514.
  23. Barrett Ronald W. (Sunnyvale CA) Pirrung Michael C. (Durham NC) Stryer Lubert (Stanford CA) Holmes Christopher P. (Sunnyvale CA) Sundberg Steven A. (San Francisco CA). Spatially-addressable immobilization of anti-ligands on surfaces. USP1993105252743.
  24. McGall Glenn H. (Mountain View CA) Fodor Stephen P. A. (Palo Alto CA) Sheldon Edward L. (Menlo Park CA). Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces. USP1995055412087.
  25. Faulk Ward P. (4414 Edinburgh Point Indianapolis IN 46208). Treatment method utilizing transferrin-radioiodine conjugate. USP1991035000935.
  26. Fodor Stephen P. A. (Palo Alto CA) Stryer Lubert (Stanford CA) Pirrung Michael C. (Durham NC) Read J. Leighton (Palo Alto CA). Very large scale immobilized polymer synthesis. USP1995065424186.
  27. Winkler James L. (Palo Alto CA) Fodor Stephen P. A. (Palo Alto CA) Buchko Christopher J. (Palo Alto CA) Ross Debra A. (Fremont CA) Aldwin Lois (San Mateo CA). Very large scale immobilized polymer synthesis using mechanically directed flow paths. USP1995015384261.

이 특허를 인용한 특허 피인용횟수: 64

  1. Shailubhai, Kunwar. Agonists of guanylate cyclase and their uses. USP20181110118946.
  2. Shailubhai, Kunwar. Agonists of guanylate cyclase and their uses. USP2017079708367.
  3. Shailubhai, Kunwar. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. USP2016119505805.
  4. Shailubhai, Kunwar. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. USP2013108569246.
  5. Shailubhai, Kunwar. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. USP2013028367800.
  6. Shailubhai, Kunwar. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. USP2014038664354.
  7. Shailubhai, Kunwar. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. USP2011108034782.
  8. Shailubhai, Kunwar; Jacob, Gary S.. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. USP2018039914752.
  9. Shailubhai, Kunwar; Jacob, Gary S.. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. USP2016019238677.
  10. Shailubhai, Kunwar; Jacob, Gary S.. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. USP2016029266926.
  11. Shailubhai, Kunwar; Jacob, Gary S.. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. USP2018039920095.
  12. Shailubhai, Kunwar; Jacob, Gary S.. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. USP2014058716224.
  13. Shailubhai, Kunwar; Jacob, Gary S.. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. USP2011027879802.
  14. Shailubhai, Kunwar; Jacob, Gary S.. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. USP2013078497348.
  15. Shailubhai, Kunwar; Jacob, Gary S.. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. USP2013018357775.
  16. Shailubhai, Kunwar; Jacob, Gary S.. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. USP2012068207295.
  17. Shailubhai, Kunwar; Jacob, Gary S.. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. USP2014128901075.
  18. Shailubhai, Kunwar. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases. USP2017119814752.
  19. Shailubhai, Kunwar. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases. USP2015038969514.
  20. Frank, Helen A.; Mcdonald, Alice; O'Keefe, Theresa L.. Anti-GCC antibody molecules and methods for use of same. USP2016039273146.
  21. Frank, Helen Alison; McDonald, Alice A.; O'Keefe, Theresa L.. Anti-GCC antibody molecules and methods for use of same. USP2015049000129.
  22. Nam, Samuel S.; Greenfield, Edward A.; O'Keefe, Theresa L.; Qin, Shixin; Babcook, John. Anti-GCC antibody molecules and related compositions and methods. USP2014078785600.
  23. Waldman, Scott A.; Park, Jason; Schulz, Stephanie. Compositions and methods for identifying and targeting cancer cells of alimentary canal origin. USP2010127854933.
  24. Waldman, Scott A.; Park, Jason; Schulz, Stephanie. Compositions and methods for identifying and targeting cancer cells of alimentary canal origin. USP2010087785817.
  25. Waldman, Scott A.; Park, Jason; Schulz, Stephanie. Compositions and methods for identifying and targeting cancer cells of alimentary canal origin. USP2015028946168.
  26. Waldman, Scott A.; Park, Jason; Schulz, Stephanie. Compositions and methods for identifying and targeting cancer cells of alimentary canal origin. USP2016089429576.
  27. Waldman, Scott A.; Park, Jason; Schulz, Stephanie. Compositions and methods for identifying and targeting cancer cells of alimentary canal origin. USP2005016844153.
  28. Waldman, Scott A.; Park, Jason; Schulz, Stephanie. Compositions and methods for identifying and targeting cancer cells of alimentary canal origin. USP2011118067007.
  29. Waldman,Scott A.; Park,Jason; Schulz,Stephanie. Compositions and methods for identifying and targeting cancer cells of alimentary canal origin. USP2009017479376.
  30. Waldman Scott A.. Compositions that specifically bind to colorectal cancer cells and methods of using the same. USP2000056060037.
  31. Waldman,Scott A.; Pearlman,Joshua M.; Barber,Michael T.; Schulz,Stephanie; Parkinson,Scott J.. Compositions that specifically bind to colorectal cancer cells and methods of using the same. USP2008017316902.
  32. Waldman,Scott A.; Park,Jason; Schulz,Stephanie. Detection of CDX2 expression. USP2009027485422.
  33. Comiskey, Stephen; Feng, Rong; Foss, John; Shailubhai, Kunwar. Formulations of guanylate cyclase C agonists and methods of use. USP2017049616097.
  34. Comiskey, Stephen; Feng, Rong; Foss, John; Shailubhai, Kunwar. Formulations of guanylate cyclase C agonists and methods of use. USP2018039925231.
  35. Comiskey, Stephen; Feng, Rong; Foss, John; Shailubhai, Kunwar. Formulations of guanylate cyclase C agonists and methods of use. USP2018039919024.
  36. Comiskey, Stephen; Feng, Rong; Foss, John; Shailubhai, Kunwar. Formulations of guanylate cyclase C agonists and methods of use. USP2017049610321.
  37. Comiskey, Stephen; Feng, Rong; Foss, John; Shailubhai, Kunwar. Formulations of guanylate cyclase C agonists and methods of use. USP20190310232011.
  38. Shailubhai, Kunwar; Comiskey, Stephen. Formulations of guanylate cyclase C agonists and methods of use. USP20180710034836.
  39. Jacob, Gary S.; Nikiforovich, Gregory; Shailubhai, Kunwar. Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis. USP2010097799897.
  40. Shailubhai, Kunwar; Nikiforovich, Gregory; Jacob, Gary S.. Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis. USP2014018637451.
  41. Shailubhai, Kunwar; Nikiforovich, Gregory; Jacob, Gary S.. Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis. USP2012028114831.
  42. Shailubhai,Kunwar; Nikiforovich,Gregory; Jacob,Gary S.. Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis. USP2006057041786.
  43. Wolfe, Hank; Waldman, Scott A.. Guanylylcyclase C ligands. USP2016099447146.
  44. Wolfe, Hank; Waldman, Scott A.. Guanylylcyclase C ligands. USP2013108563682.
  45. Waldman, Scott A. Metastatic colorectal cancer vaccine. USP2012128329881.
  46. Waldman, Scott A.. Metastatic colorectal cancer vaccine. USP2009107598229.
  47. Currie,Mark G.; Mahajan Miklos,Shalina; Sun,Li Jing; Kurtz,Caroline. Method for treating congestive heart failure and other disorders. USP2009027494979.
  48. Shailubhai, Kunwar. Method of inhibiting bile acid absorption by administering an agonist of a guanylate cyclase receptor. USP2015079089612.
  49. Currie, Mark G.; Mahajan-Miklos, Shalina; Sun, Li Jing. Methods and compositions for the treatment of gastrointestinal disorders. USP2012018101579.
  50. Currie, Mark G.; Mahajan-Miklos, Shalina; Sun, Li Jing. Methods and compositions for the treatment of gastrointestinal disorders. USP2017129840536.
  51. Waldman,Scott A.. Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof. USP2008077402401.
  52. Waldman, Scott A.; Park, Jason; Schulz, Stephanie. Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression. USP2004076767704.
  53. Waldman, Scott A.; Pearlman, Joshua M.; Barber, Michael T.; Schulz, Stephanie; Parkinson, Scott J.; Prawer, Scott. Methods of using CRCA-1 as a stomach and esophageal cancer marker. USP2010117829276.
  54. Goy, Michael F.; Moss, Nicholas G.; Qian, Xun. Prouroguanylin, and synthetic analogs or proteolytic cleavage products derived from it, as therapeutic and diagnostic agents for diseases involving salt and/or fluid homeostasis. USP2012058173596.
  55. Waldman, Scott A.. ST receptor binding compounds and methods of using the same. USP2010067744870.
  56. Currie, Mark G.; Fretzen, Angelika; Kessler, Marco; Zimmer, Daniel P.. Treatments for gastrointestinal disorders. USP2013088507447.
  57. Currie, Mark G.; Zimmer, Daniel P.; Fretzen, Angelika; Kessler, Marco. Treatments for gastrointestinal disorders. USP2017059650417.
  58. Currie, Mark G.; Zimmer, Daniel P.; Fretzen, Angelika; Kessler, Marco; Cali, Brian. Treatments for gastrointestinal disorders. USP2014058735360.
  59. Currie, Mark G.; Zimmer, Daniel P.; Fretzen, Angelika; Kessler, Marco; Cali, Brian M.. Treatments for gastrointestinal disorders. USP2016129527887.
  60. Currie, Mark G.; Zimmer, Daniel P.; Fretzen, Angelika; Kessler, Marco; Cali, Brian M.. Treatments for gastrointestinal disorders. USP2017049617305.
  61. Currie, Mark G.; Zimmer, Daniel P.; Kessler, Marco. Treatments for gastrointestinal disorders. USP2016049303066.
  62. Currie, Mark G.; Fretzen, Angelika; Kessler, Marco; Zimmer, Daniel. Treatments of gastrointestinal disorders. USP2015028946158.
  63. Waldman, Scott A.; Pitari, Giovanni Mario; Park, Jason; Schulz, Stephanie; Wolfe, Henry R.; Lubbe, Wilhelm. Use of GCC ligands. USP2012068206704.
  64. Harris,Thomas D.; Barrett,John A.; Carpenter, Jr.,Alan P.; Rajopadhye,Milind. Vitronectin receptor antagonist pharmaceuticals. USP2006037018611.